Dr. Carla Rothlin is a Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at Yale School of Medicine. She is also Co-Leader of the Cancer Immunology Program at the Yale Cancer Center and the Director of Graduate Studies in Immunobiology. Dr. Rothlin studied Biochemistry and Pharmacy at the University of Buenos Aires, where she also obtained her Ph.D. in 2002. Following her Ph.D., she moved to San Diego, California, for her postdoctoral studies at the Salk Institute for Biological Studies. Dr. Rothlin co-directs a laboratory with Dr. Sourav Ghosh. They have a long-term interest in how the immune response is calibrated to avoid chronic inflammation, autoimmunity, and self-harm. One of the current interests in the lab is cell death and its clearance, and how this can function as a signal for specific effector responses during morphogenesis, homeostatic tissue renewal, or resolution and wound repair after damage. Dr. Rothlin has received a number of honors and awards, such as the Senior Research Award from the Crohn’s and Colitis Foundation of America in 2010, the Novel Research Grant from the Lupus Research Institute in 2011, the Early Excellence Award from the American Asthma Foundation in 2011, and the HHMI Faculty Scholar from the Howard Hughes Medical Institute in 2016.
Dr. Carla Rothlin is a Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at Yale School of Medicine. She is also Co-Leader of the Cancer Immunology Program at the Yale Cancer Center and the Director of Graduate Studies in Immunobiology. Dr. Rothlin studied Biochemistry and Pharmacy at the University of Buenos Aires, where she also obtained her Ph.D. in 2002. Following her Ph.D., she moved to San Diego, California, for her postdoctoral studies at the Salk Institute for Biological Studies. Dr. Rothlin co-directs a laboratory with Dr. Sourav Ghosh. They have a long-term interest in how the immune response is calibrated to avoid chronic inflammation, autoimmunity, and self-harm. One of the current interests in the lab is cell death and its clearance, and how this can function as a signal for specific effector responses during morphogenesis, homeostatic tissue renewal, or resolution and wound repair after damage. Dr. Rothlin has received a number of honors and awards, such as the Senior Research Award from the Crohn’s and Colitis Foundation of America in 2010, the Novel Research Grant from the Lupus Research Institute in 2011, the Early Excellence Award from the American Asthma Foundation in 2011, and the HHMI Faculty Scholar from the Howard Hughes Medical Institute in 2016.